GOOGL
61
-11
LYB
41
4
NKE
39
2
NOV
48
3
BLK
69
11
NRG
72
-2
CFG
56
4
BIIB
45
-3
PPL
67
-2
IRM
71
-2
RCL
62
-3
BXP
52
-2
STI
15
-5
SRE
61
14
PRU
59
2
JCI
44
2
NTAP
72
10
HD
35
-11
UHS
60
-3
MTCH
44
-2
GOOGL
61
-11
LYB
41
4
NKE
39
2
NOV
48
3
BLK
69
11
NRG
72
-2
CFG
56
4
BIIB
45
-3
PPL
67
-2
IRM
71
-2
RCL
62
-3
BXP
52
-2
STI
15
-5
SRE
61
14
PRU
59
2
JCI
44
2
NTAP
72
10
HD
35
-11
UHS
60
-3
MTCH
44
-2
Financhill
Back

MeridianLink 10K Form

Buy
55

MLNK
MeridianLink

Last Price:
18.42
Seasonality Move:
11.64%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive MLNK News And Ratings

See the #1 stock for the next 7 days that we like better than MLNK

MLNK Financial Statistics

Sales & Book Value

Annual Sales: $303.62M
Cash Flow: $27.11M
Price / Cash Flow: 24.32
Annual Sales: $6.11
Price / Book: 2.96

Profitability

EPS (TTM): -0.53000
Net Income (TTM): $-42.18M
Gross Margin: $195.13M
Return on Equity: -7.86%
Return on Assets: -4.09%

MeridianLink Earnings Forecast

Key MeridianLink Financial Ratios

  • The Gross Profit Margin over the past 18 years for MLNK is 64.27%.
  • The Selling, General & Administrative Expenses for MLNK have been equal to 42.31% of Gross Profit Margin.
  • The Research & Development expenses have been 15.65% of Revenue.
  • The Interest Expense is -89.70% of Operating Income.
  • The Net Earning history of MLNK is -14.01% of Total Revenues.
  • Per Share Earnings over the last 18 years have been positive in 7 years.

MeridianLink Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Software
Sector: Information Technology
Current Symbol: MLNK
Website: meridianlink.com

Debt

Debt-to-Equity Ratio: 0.91
Current Ratio: 1.51
Quick Ratio: 1.35

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 35.81

MLNK Technical Analysis vs Fundamental Analysis

Buy
55
MeridianLink (MLNK) is a Buy

Is MeridianLink a Buy or a Sell?

  • MeridianLink stock is rated a Buy
    The current MeridianLink [MLNK] share price is $18.00. The Score for MLNK is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.